Optimization of Potent and Selective Tricyclic Indole Diazepinone Myeloid Cell Leukemia-1 Inhibitors Using...

Area of Science:

• Oncology
• Molecular Biology
• Drug Discovery

Background:

• Myeloid cell leukemia 1 (Mcl-1) is an anti-apoptotic protein.
• Mcl-1 upregulation is linked to cancer progression, poor survival, and chemotherapy resistance.
• Mcl-1 is a promising therapeutic target in oncology.

Purpose of the Study:

• To discover and optimize novel Mcl-1 inhibitors.
• To develop potent and selective small molecules targeting Mcl-1.
• To explore the therapeutic potential of Mcl-1 inhibition in cancer.

Main Methods:

• Structure-based drug design was employed for inhibitor optimization.
• A series of tricyclic indole diazepinone compounds were synthesized.
• Binding affinity and cellular efficacy assays were performed.

Main Results:

• Discovered potent and selective tricyclic indole diazepinone Mcl-1 inhibitors.
• Achieved picomolar binding affinity for Mcl-1.
• Demonstrated mechanism-based cellular efficacy, including growth inhibition and caspase induction.

Conclusions:

• Developed promising Mcl-1 inhibitors with high potency and selectivity.
• These compounds are valuable tools for studying Mcl-1's role in cancer.
• The inhibitors serve as potential starting points for anti-Mcl-1 cancer therapeutics.